TRAIL, Fas Ligand, TNF and TLR3 in Cancer(Resistance to Targeted Anti-Cancer Therapeutics)

肿瘤学

原   价:
2846.25
售   价:
2277.00
优惠
平台大促 低至8折优惠
发货周期:外国库房发货,通常付款后3-5周到货
出  版 社
出版时间
2018年08月12日
装      帧
平装
ISBN
9783319860060
复制
页      码
317
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 50 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
This volume provides the current understanding of death receptor’s/TLR3 signaling regulation in cancer. Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy. But an increasing body of evidence suggests that some of these receptors may also contribute to tumorigenesis, or that new players such as TLR3 may be targeted for cancer therapy due to their ability to behave like death receptors.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个